...
首页> 外文期刊>Veterinary Parasitology >Evaluation of the persistent activity of moxidectin (10%) long-acting (LA) injectable formulation against Dictyocaulus viviparus, Haemonchus placei, Trichostrongylus axei and Oesophagostomum radiatum infections in cattle
【24h】

Evaluation of the persistent activity of moxidectin (10%) long-acting (LA) injectable formulation against Dictyocaulus viviparus, Haemonchus placei, Trichostrongylus axei and Oesophagostomum radiatum infections in cattle

机译:评估莫西菌素(10%)长效(LA)注射剂对牛的毛ic虫,Haemonchus placei,Trichostrongylus axei和Oesophagostomum radiatum感染的持久活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Two controlled studies were conducted to evaluate the persistent efficacy of moxidectin (10%) long-acting (LA) injectable formulation against Dictyocaulus viviparus, Haemonchus placei, Trichostrongylus axei and Oesophagostomum radiatum in cattle. The moxidectin LA injectable formulation was administered as a single subcutaneous injection into the proximal third of the ear at a dose rate of 0.01ml/kg BW to provide 1.0mg moxidectin/kg BW. The product had persistent efficacy of >90% against D. viviparus, H. placei and Oe. radiatum for at least 150 days post-treatment and against T. axei for at least 90 days post-treatment.
机译:进行了两项对照研究,以评估莫西菌素(10%)长效(LA)注射剂在牛体内对滴虫,产黄曲霉,轴突毛线虫和放射食道杆菌的持续疗效。 moxidectin LA可注射制剂以单次皮下注射的方式以0.01ml / kg BW的剂量率给药到耳朵的近端三分之一,以提供1.0mg moxidectin / kg BW。该产品对D. viviparus,H。Placei和Oe的持久效力> 90%。放射治疗后至少需要150天,而抗轴心线虫需要至少90天。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号